Sinai Health System, Toronto, Canada.
Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
Diabet Med. 2018 Apr;35(4):430-435. doi: 10.1111/dme.13585. Epub 2018 Feb 15.
To review the current literature on the use of continuous glucose monitoring during pregnancy in women with Type 1 diabetes.
We searched the literature for randomized controlled trials using continuous glucose monitoring during pregnancy in women with Type 1 diabetes.
Three randomized trials were found and discussed in this review. One UK study found a reduction in large-for-gestational-age infants; however, only masked continuous glucose monitoring was used in that study. A Danish study used intermittent real-time continuous glucose monitoring and found no differences. The present authors conducted the CONCEPTT trial, in which pregnant women and women planning pregnancy were randomized to receive continuous glucose monitoring or standard care. We found a greater drop in HbA , more time spent in the target range, and a reduction in some adverse neonatal outcomes in women using continuous glucose monitoring. Numbers-needed-to-treat to prevent a large-for-gestational-age infant, a neonatal intensive care unit admission for >24 h, and a neonatal hypoglycaemia event were low. These findings were seen in both injection and pump users and across all countries. Possible reasons for differences in study findings are discussed. In addition, several issues need further study. Glycaemic variability and differences in dietary intake may also have played a role. Despite excellent glycaemic control, babies continue to be large. More research is needed to understand the role of glucose targets and the dynamic placental processes involved in fetal growth.
The use of continuous glucose monitoring in women with Type 1 diabetes in pregnancy is associated with improved glycaemic control and neonatal outcomes. Further research examining the glycaemic and non-glycaemic variables involved in fetal growth and the cost-benefit of using continuous glucose monitoring in pregnancy is warranted.
回顾目前关于 1 型糖尿病女性在妊娠期间使用连续血糖监测的文献。
我们检索了在妊娠期间使用连续血糖监测的 1 型糖尿病女性的随机对照试验文献。
在本综述中讨论了三项随机试验。一项英国研究发现,巨大儿的发生率降低;然而,该研究仅使用了掩蔽式连续血糖监测。一项丹麦研究使用了间歇性实时连续血糖监测,并未发现差异。本作者进行了 CONCEPTT 试验,该试验将孕妇和计划怀孕的女性随机分为接受连续血糖监测或标准护理组。我们发现,使用连续血糖监测的女性 HbA 下降更大,目标范围内的时间更多,一些不良新生儿结局减少。需要治疗的人数以预防巨大儿、新生儿重症监护病房住院>24 小时和新生儿低血糖事件的发生较少。这些发现见于注射和泵使用者以及所有国家。讨论了研究结果存在差异的可能原因。此外,还需要进一步研究一些问题。血糖变异性和饮食摄入的差异也可能起作用。尽管血糖控制良好,但婴儿仍然较大。需要进一步研究来了解血糖目标和涉及胎儿生长的动态胎盘过程的作用。
1 型糖尿病女性在妊娠期间使用连续血糖监测与改善血糖控制和新生儿结局相关。需要进一步研究涉及胎儿生长的血糖和非血糖变量以及在妊娠期间使用连续血糖监测的成本效益。